Dr.Surbhi Kansal and Mainsha Jain (2026) “IN VITRO SUSCEPTIBILITY PROFILES OF FTOLOZANE–TAZOBACTAM AND CEFTAZIDIME–AVIBACTAM AGAINST AMPC/ ESBL PRODUCING ENTEROBACTERIACEAE”, Journal of Population Therapeutics and Clinical Pharmacology, 33(2), pp. 841–852. doi:10.69980/1gsrfr34.